Arthritis, often thought to be an ailment of the elderly, is an autoimmune disease prevalent across all ages, particularly in ...

ADI-001 clinical development program now addresses six autoimmune diseases. Patient enrollment for idiopathic inflammatory myopathy and stiff person syndrome cohort expected to be ...

Faricimab, a humanized, bispecific, immunoglobulin G monoclonal antibody, received FDA approval as an intravitreal injection ...

Several forms of inflammation can be distinguished histologically; interestingly, although the disease typically presents with engorgement of scleral vessels, vasculitis is not universally present ...

Factors associated with increased flare rates post-vaccination included active disease at the time, female sex, and -- most ...

Completes Transition to Immune-Mediated Disease Focused CompanyHighlights Additional Data from Phase 1b Primary Membranous ...

Dr. Jonathan Hendrie is now accepting patients at the Lake Cumberland Rheumatology and Infusion Center of <a target=_blank href= ...

WELLESLEY, Mass., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), announced that it will present data at ...

Q32 Bio Inc. (NASDAQ:QTTB – Get Free Report) has received an average recommendation of “Buy” from the six brokerages that are covering the company, Marketbeat Ratings reports. Five equities research ...

By Jula Inrig, M.D. Chief Medical Officer, Travere Therapeutics | When a specialized field of medicine has long been quiet, a ...

(NASDAQ:ARGX – Get Free Report)‘s stock had its “strong-buy” rating reaffirmed by investment analysts at Raymond James in a note issued to investors on Thursday, MarketBeat.com reports. They currently ...